Enhancement of T cell responses as a result of synergy between lower doses of radiation and T cell stimulation

Journal of Immunology

Volumn 192, Issue 7, 2014, Pages 3101-3110

  Spary, Lisa K ^a   Al Taei, Saly ^a   Salimu, Josephine ^a   Cook, Alexander D ^a   Ager, Ann ^a   Angharad Watson, H ^a   Clayton, Aled ^a   Staffurth, John ^a   Mason, Malcolm D ^a   Tabi, Zsuzsanna ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RO ANTIGEN; GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B;

ANTIGEN STIMULATION ASSAY; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE REDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL;

AMINO ACID SEQUENCE; ANTIGENS, CD45; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, RADIATION; EPITOPES, T-LYMPHOCYTE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; GLUCOSE; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; PEPTIDES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 84897536947     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302736     Document Type: Article

References (40)

1. Takeshima, T., K. Chamoto, D. Wakita, T. Ohkuri, Y. Togashi, H. Shirato, H. Kitamura, and T. Nishimura. 2010. Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res. 70: 2697-2706.
2. Lee, Y., S. L. Auh, Y. Wang, B. Burnette, Y. Wang, Y. Meng, M. Beckett, R. Sharma, R. Chin, T. Tu, et al. 2009. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 114: 589-595.
3. Hodge, J. W., H. J. Sharp, and S. R. Gameiro. 2012. Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiation. Cancer Biother. Radiopharm. 27: 12-22.
4. Dewan, M. Z., A. E. Galloway, N. Kawashima, J. K. Dewyngaert, J. S. Babb, S. C. Formenti, and S. Demaria. 2009. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin. Cancer Res. 15: 5379-5388.
5. Barrio, M. M., R. Abes, M. Colombo, G. Pizzurro, C. Boix, M. P. Roberti, E. Gélizé, M. Rodriguez-Zubieta, J. Mordoh, and J. L. Teillaud. 2012. Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells. PLoS One 7: e40311.
6. von Euw, E. M., M. M. Barrio, D. Furman, M. Bianchini, E. M. Levy, C. Yee, Y. Li, R. Wainstok, and J. Mordoh. 2007. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes. J. Transl. Med. 5: 19.
7. Apetoh, L., F. Ghiringhelli, A. Tesniere, M. Obeid, C. Ortiz, A. Criollo, G. Mignot, M. C. Maiuri, E. Ullrich, P. Saulnier, et al. 2007. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 13: 1050-1059.
8. Zeng, J., A. P. See, J. Phallen, C. M. Jackson, Z. Belcaid, J. Ruzevick, N. Durham, C. Meyer, T. J. Harris, E. Albesiano, et al. 2013. Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int. J. Radiat. Oncol. Biol. Phys. 86: 343-349.
9. Martin, N. E., and A. K. Ng. 2009. Good things come in small packages: lowdose radiation as palliation for indolent non-Hodgkin lymphomas. Leuk. Lymphoma 50: 1765-1772.
10. Lukens, J. N., S. D. Nasta, B. Fram, E. Glatstein, and J. P. Plastaras. 2014. Outcomes after involved-field radiation therapy (IFRT) with or without Rituximab in patients with early-stage low-grade non-Hodgkin lymphoma (NHL) staged with CT and PET. Am. J. Clin. Oncol. 37: 35-40.
11. Knoops, L., R. Haas, S. de Kemp, D. Majoor, A. Broeks, E. Eldering, J. P. de Boer, M. Verheij, C. van Ostrom, A. de Vries, et al. 2007. In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma. Blood 110: 1116-1122.
12. Hashimoto, S., H. Shirato, M. Hosokawa, T. Nishioka, Y. Kuramitsu, K. Matushita, M. Kobayashi, and K. Miyasaka. 1999. The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats. Radiat. Res. 151: 717-724.
13. Brody, J. D., W. Z. Ai, D. K. Czerwinski, J. A. Torchia, M. Levy, R. H. Advani, Y. H. Kim, R. T. Hoppe, S. J. Knox, L. K. Shin, et al. 2010. In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study. J. Clin. Oncol. 28: 4324-4332.
14. Weng, L., R. O. Williams, P. L. Vieira, G. Screaton, M. Feldmann, and F. Dazzi. 2010. The therapeutic activity of low-dose irradiation on experimental arthritis depends on the induction of endogenous regulatory T cell activity. Ann. Rheum. Dis. 69: 1519-1526.
15. Balogh, A., E. Persa, E. N. Bogdándi, A. Benedek, H. Hegyesi, G. Sáfrány, and K. Lumniczky. 2013. The effect of ionizing radiation on the homeostasis and functional integrity of murine splenic regulatory T cells. Inflamm. Res. 62: 201-212.
16. Nogami, M., J. T. Huang, L. T. Nakamura, and T. Makinodan. 1994. T cells are the cellular target of the proliferation-augmenting effect of chronic low-dose ionizing radiation in mice. Radiat. Res. 139: 47-52.
17. Tabi, Z., L. K. Spary, S. Coleman, A. Clayton, M. D. Mason, and J. Staffurth. 2010. Resistance of CD45RA2 T cells to apoptosis and functional impairment, and activation of tumor-antigen specific T cells during radiation therapy of prostate cancer. J. Immunol. 185: 1330-1339.
18. Marko, A. J., R. A. Miller, A. Kelman, and K. A. Frauwirth. 2010. Induction of glucose metabolism in stimulated T lymphocytes is regulated by mitogenactivated protein kinase signaling. PLoS One 5: e15425.
19. Frauwirth, K. A., J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell, D. R. Plas, R. L. Elstrom, C. H. June, and C. B. Thompson. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16: 769-777.
20. Shingler, W. H., P. Chikoti, S. M. Kingsman, and R. Harrop. 2008. Identification and functional validation of MHC class I epitopes in the tumor-associated antigen 5T4. Int. Immunol. 20: 1057-1066.
21. Al-Taei, S., J. Salimu, J. F. Lester, S. Linnane, M. Goonewardena, R. Harrop, M. D. Mason, and Z. Tabi. 2012. Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma. Lung Cancer 77: 312-318.
22. Khan, N., M. Cobbold, R. Keenan, and P. A. H. Moss. 2002. Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. J. Infect. Dis. 185: 1025-1034.
23. Kinet, S., L. Swainson, M. Lavanya, C. Mongellaz, A. Montel-Hagen, M. Craveiro, N. Manel, J. L. Battini, M. Sitbon, and N. Taylor. 2007. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells. Retrovirology 4: 31.
24. Singh, K., P. Deshpande, S. Pryshchep, I. Colmegna, V. Liarski, C. M. Weyand, and J. J. Goronzy. 2009. ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis. J. Immunol. 183: 8258-8267.
25. Prinz, P. U., A. N. Mendler, I. Masouris, L. Durner, R. Oberneder, and E. Noessner. 2012. High DGK-a and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic intervention. J. Immunol. 188: 5990-6000.
26. Salmond, R. J., J. Emery, K. Okkenhaug, and R. Zamoyska. 2009. MAPK, phosphatidylinositol 3-kinase, and mammalian target of rapamycin pathways converge at the level of ribosomal protein S6 phosphorylation to control metabolic signaling in CD8 T cells. J. Immunol. 183: 7388-7397.
27. Burnette, B., Y. X. Fu, and R. R. Weichselbaum. 2012. The confluence of radiotherapy and immunotherapy. Front. Oncol. 2: 143.
28. Gupta, A., H. C. Probst, V. Vuong, A. Landshammer, S. Muth, H. Yagita, R. Schwendener, M. Pruschy, A. Knuth, and M. van den Broek. 2012. Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation. J. Immunol. 189: 558-566.
29. Jahns, J., U. Anderegg, A. Saalbach, B. Rosin, I. Patties, A. Glasow, M. Kamprad, M. Scholz, and G. Hildebrandt. 2011. Influence of low dose irradiation on differentiation, maturation and T-cell activation of human dendritic cells. Mutat. Res. 709-710: 32-39.
30. Hommel, M., and P. D. Hodgkin. 2007. TCR affinity promotes CD8+ T cell expansion by regulating survival. J. Immunol. 179: 2250-2260.
31. Shen, C., C. S. Lancaster, B. Shi, H. Guo, P. Thimmaiah, and M. A. Bjornsti. 2007. TOR signaling is a determinant of cell survival in response to DNA damage. Mol. Cell. Biol. 27: 7007-7017.
32. Sunavala-Dossabhoy, G., M. Fowler, and A. De Benedetti. 2004. Translation of the radioresistance kinase TLK1B is induced by gamma-irradiation through activation of mTOR and phosphorylation of 4E-BP1. BMC Mol. Biol. 5: 1.
33. Reits, E. A., J. W. Hodge, C. A. Herberts, T. A. Groothuis, M. Chakraborty, E. K. Wansley, K. Camphausen, R. M. Luiten, A. H. de Ru, J. Neijssen, et al. 2006. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J. Exp. Med. 203: 1259-1271.
34. Sanli, T., A. Rashid, C. Liu, S. Harding, R. G. Bristow, J. C. Cutz, G. Singh, J. Wright, and T. Tsakiridis. 2010. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 78: 221-229.
35. Tamás, P., S. A. Hawley, R. G. Clarke, K. J. Mustard, K. Green, D. G. Hardie, and D. A. Cantrell. 2006. Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. J. Exp. Med. 203: 1665-1670.
36. Stefanová, I., B. Hemmer, M. Vergelli, R. Martin, W. E. Biddison, and R. N. Germain. 2003. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat. Immunol. 4: 248-254.
37. Robertson, L. K., L. R. Mireau, and H. L. Ostergaard. 2005. A role for phosphatidylinositol 3-kinase in TCR-stimulated ERK activation leading to paxillin phosphorylation and CTL degranulation. J. Immunol. 175: 8138-8145.
38. Finlay, D., and D. A. Cantrell. 2011. Metabolism, migration and memory in cytotoxic T cells. Nat. Rev. Immunol. 11: 109-117.
39. Braunstein, S., M. L. Badura, Q. Xi, S. C. Formenti, and R. J. Schneider. 2009. Regulation of protein synthesis by ionizing radiation. Mol. Cell. Biol. 29: 5645-5656.
40. Reissfelder, C., C. Timke, H. Schmitz-Winnenthal, N. N. Rahbari, M. Koch, F. Klug, F. Roeder, L. Edler, J. Debus, M. W. Büchler, et al. 2011. A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer. BMC Cancer 11: 419.